In addition to modulating acute inflammation, we now demonstrate a role for IL-25 in orchestrating airway remodelling. IL-25 also drives IL-33 and TSLP production in the lung. These data delineate a wider role for IL-25 in mediating structural changes to the lung following allergen exposure and implicate IL-25 as a novel therapeutic target for the treatment of airway remodelling in asthma.
No takes yet. Share an insight, caveat, or question.
Gregory et al. (2012) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: